Mammalian MYC Proteins and Cancer
Open Access
- 2 February 2014
- journal article
- review article
- Published by Hindawi Limited in New Journal of Science
- Vol. 2014, 1-27
Abstract
The MYC family of proteins is a group of basic-helix-loop-helix-leucine zipper transcription factors that feature prominently in cancer. Overexpression of MYC is observed in the vast majority of human malignancies and promotes an extraordinary set of changes that impact cell proliferation, growth, metabolism, DNA replication, cell cycle progression, cell adhesion, differentiation, and metastasis. The purpose of this review is to introduce the reader to the mammalian family of MYC proteins, highlight important functional properties that endow them with their potent oncogenic potential, describe their mechanisms of action and of deregulation in cancer cells, and discuss efforts to target the unique properties of MYC, and of MYC-driven tumors, to treat cancer.Keywords
This publication has 312 references indexed in Scilit:
- Tumor suppressor functions of FBW7 in cancer development and progressionFEBS Letters, 2012
- MYC on the Path to CancerCell, 2012
- BET Bromodomain Inhibition as a Therapeutic Strategy to Target c-MycCell, 2011
- Hallmarks of Cancer: The Next GenerationCell, 2011
- Myc-Nick: A Cytoplasmic Cleavage Product of Myc that Promotes α-Tubulin Acetylation and Cell DifferentiationCell, 2010
- Distinct Thresholds Govern Myc's Biological Output In VivoCancer Cell, 2008
- Deregulation of Scribble Promotes Mammary Tumorigenesis and Reveals a Role for Cell Polarity in CarcinomaCell, 2008
- The multi-tasking P-TEFb complexCurrent Opinion in Cell Biology, 2008
- Induction of Pluripotent Stem Cells from Mouse Embryonic and Adult Fibroblast Cultures by Defined FactorsCell, 2006
- The c-myc oncogene perturbs B lymphocyte development in Eμ-myc transgenic miceCell, 1986